Vreugdenhil P K, Ametani M S, Haworth R A, Southard J H
Department of Surgery, University of Wisconsin, Madison 53792, USA.
Transplantation. 1999 Jun 15;67(11):1468-73. doi: 10.1097/00007890-199906150-00013.
A complication in liver transplantation is increased clotting times due to inhibition of protein synthesis resulting from prolonged hypothermic preservation. Protein synthesis is also blocked in cold preserved hepatocytes. In this study, the mechanism of inhibition of protein synthesis in cold preserved hepatocytes was investigated.
Hepatocytes prepared from rat liver were cold preserved in University of Wisconsin solution for 4, 24, and 48 hr. Protein synthesis was measured as incorporation of radiolabeled leucine into acid precipitable proteins. Hepatocytes were treated with antioxidants (dithiothreitol, trolox or deferoxamine, nitric oxide synthase inhibitor (N(G)-monomethyl-L-arginine monoacetate), steroids (dexamethasone or methylprednisolone), methods to keep adenosine triphosphate high (aerobic storage), and cytoskeletal disrupting agents (cytochalasin D or colchicine).
There was a 26% decrease in protein synthesis after only 4 hr of cold storage and a further 25% decrease at 24 hr. Antioxidants, elevated adenosine triphosphate, and N(G)-monomethyl-L-arginine monoacetate did not affect the rate of loss of protein synthesis. Protein synthesis was not due to inhibition of amino acid transport or lack of amino acids in the storage medium. Steroid pretreatment of hepatocytes had no effect on the loss of protein synthesis occurring in the first 4 hr of storage but did suppress the loss occurring during the next 44 hr of storage. Cytoskeletal disrupting agents, added to freshly isolated cells, inhibited protein synthesis.
The mechanism of loss of protein synthesis in cold preserved liver cells is not mediated by: (1) oxygen free radical generation or improved by antioxidant therapy, (2) nitric oxide generation in hepatocytes, (3) an adenosine triphosphate-sensitive destruction of cell viability, and (4) decreased permeability of amino acids or loss of amino acids from the cells. Loss of protein synthesis due to hypothermic storage appears biphasic. The first phase, occurring within 4 hr of storage, may be the result of the effects of hypothermia on the cell cytoskeletal system and may be untreatable. The second phase, which occurs during the next 24 to 48 hr is sensitive to steroid pretreatment. This phase may be amenable to improved preservation methodology. Improved preservation of the liver may require the use of steroids to conserve protein synthetic capabilities.
肝移植中的一个并发症是由于长时间低温保存导致蛋白质合成受抑制,从而使凝血时间延长。蛋白质合成在低温保存的肝细胞中也会受阻。在本研究中,对低温保存肝细胞中蛋白质合成受抑制的机制进行了研究。
从大鼠肝脏制备的肝细胞在威斯康星大学溶液中低温保存4、24和48小时。蛋白质合成通过放射性标记的亮氨酸掺入酸不溶性蛋白质中来测定。肝细胞用抗氧化剂(二硫苏糖醇、生育三烯酚或去铁胺)、一氧化氮合酶抑制剂(N(G)-单甲基-L-精氨酸单乙酸盐)、类固醇(地塞米松或甲泼尼龙)、保持三磷酸腺苷水平高的方法(有氧储存)以及细胞骨架破坏剂(细胞松弛素D或秋水仙碱)进行处理。
仅低温保存4小时后蛋白质合成下降26%,24小时时进一步下降25%。抗氧化剂、升高的三磷酸腺苷和N(G)-单甲基-L-精氨酸单乙酸盐对蛋白质合成的损失率没有影响。蛋白质合成下降并非由于氨基酸转运受抑制或储存培养基中缺乏氨基酸。肝细胞的类固醇预处理对储存最初4小时内发生的蛋白质合成损失没有影响,但确实抑制了接下来44小时内发生的损失。添加到新鲜分离细胞中的细胞骨架破坏剂抑制蛋白质合成。
低温保存肝细胞中蛋白质合成损失的机制不是由以下因素介导的:(1)氧自由基生成或抗氧化治疗改善,(2)肝细胞中一氧化氮生成,(3)三磷酸腺苷敏感的细胞活力破坏,以及(4)氨基酸通透性降低或细胞内氨基酸损失。低温保存导致的蛋白质合成损失似乎呈双相性。第一阶段,发生在储存4小时内,可能是低温对细胞骨架系统影响的结果,可能无法治疗。第二阶段,发生在接下来的24至48小时,对类固醇预处理敏感。这个阶段可能适合改进保存方法。改善肝脏保存可能需要使用类固醇来保留蛋白质合成能力。